Drug Type Bispecific antibody |
Synonyms MCLA-134 |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors), TIM3 inhibitors(Hepatitis A virus cellular receptor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | - |